Fudan University

Zhihu Inc. Appoints New Director and Chief Financial Officer

Retrieved on: 
Monday, January 2, 2023
Hong Kong Stock Exchange, NYSE, Maus, Q&A, Goldman Sachs, Metropolitan Stock Exchange, Stock exchange, China Media Capital, CIC, Fudan University, Management, Zhihu, PRC

BEIJING, Jan. 2, 2023 /PRNewswire/ -- Zhihu Inc. ("Zhihu" or the "Company") (NYSE: ZH; HKEX: 2390), the operator of Zhihu, a leading online content community in China, today announced that its board of directors has appointed Mr. Henry Dachuan Sha as a Director and the Chief Financial Officer of the Company, effective immediately.

Key Points: 
  • BEIJING, Jan. 2, 2023 /PRNewswire/ -- Zhihu Inc. ("Zhihu" or the "Company") (NYSE: ZH; HKEX: 2390), the operator of Zhihu, a leading online content community in China, today announced that its board of directors has appointed Mr. Henry Dachuan Sha as a Director and the Chief Financial Officer of the Company, effective immediately.
  • Mr. Sha will replace Mr. Wei Sun, who has tendered his resignation from the positions of director and chief financial officer to pursue other business endeavors.
  • Prior to joining Zhihu, Mr. Sha served as the Chief Financial Officer of Quwan Holding Limited between October 2020 and December 2022.
  • From September 2017 to December 2019, Mr. Sha served as the Chief Financial Officer of Huya Inc. (NYSE: HUYA).

CGTN: New Approaches: Why China is easing its COVID-19 curbs now

Retrieved on: 
Tuesday, December 20, 2022
Death, World Health Organization, Vaccination, Severe acute respiratory syndrome coronavirus 2, Nature, Patient, Mutation, Respiratory disease, Laboratory, Hainan Medical University, Science Advances, COVID, National Institutes of Health, Routing protocol, Disease, University, Hong Kong residents, Alpha, COVID-19, Chinese Center for Disease Control and Prevention, Infection, Social mobility, Center for Infectious Disease Research and Policy, Virology, Mouse, Fudan University, Diagnosis, Economic development, Gamma, Sun, National Health Commission, Ageing, Virulence, Huashan Hospital, Animal, Pharmaceutical industry, Vaccine, Delta, Omicron

By November when China announced its new policies to relax a series of stringent measures meant to monitor and cut the spread of COVID-19, the country had reported over 5,000 deaths caused by this virus.

Key Points: 
  • By November when China announced its new policies to relax a series of stringent measures meant to monitor and cut the spread of COVID-19, the country had reported over 5,000 deaths caused by this virus.
  • The low death toll, out of a population of 1.4 billion, did not come easily.
  • As many countries tried and gave up stricter measures one after another in the past three years, China didn't follow.
  • Data showed that Omicron replicates to lower levels than the Delta in rhesus macaques, resulting in reduced clinical disease.

CGTN: New Approaches: Why China is easing its COVID-19 curbs now

Retrieved on: 
Tuesday, December 20, 2022
Death, World Health Organization, Vaccination, Severe acute respiratory syndrome coronavirus 2, Nature, Patient, Mutation, Respiratory disease, Laboratory, Hainan Medical University, Science Advances, COVID, National Institutes of Health, Routing protocol, Disease, University, Hong Kong residents, Alpha, COVID-19, Chinese Center for Disease Control and Prevention, Infection, Social mobility, Center for Infectious Disease Research and Policy, Virology, Mouse, Fudan University, Diagnosis, Economic development, Gamma, Sun, National Health Commission, Ageing, Virulence, Huashan Hospital, Animal, Pharmaceutical industry, Vaccine, Delta, Omicron

By November when China announced its new policies to relax a series of stringent measures meant to monitor and cut the spread of COVID-19, the country had reported over 5,000 deaths caused by this virus.

Key Points: 
  • By November when China announced its new policies to relax a series of stringent measures meant to monitor and cut the spread of COVID-19, the country had reported over 5,000 deaths caused by this virus.
  • The low death toll, out of a population of 1.4 billion, did not come easily.
  • As many countries tried and gave up stricter measures one after another in the past three years, China didn't follow.
  • Data showed that Omicron replicates to lower levels than the Delta in rhesus macaques, resulting in reduced clinical disease.

Global Times survey: over 60% participants believe China's global influence rising; world concern war, energy & foods crises more than pandemic

Retrieved on: 
Monday, December 19, 2022
School, Belt and Road Initiative, Northeast Project of the Chinese Academy of Social Sciences, Attitude, Public affairs, Global Times, Social science, Belt, COVID-19, Conference, News, Fudan University, Food, Science, Research, Renewable energy, Tourism

Analysts said the survey reflects that the world welcomes and has strong confidence in China's development and Chinese modernization.

Key Points: 
  • Analysts said the survey reflects that the world welcomes and has strong confidence in China's development and Chinese modernization.
  • more than 30 percent among all participants worldwide believe the US' influence is rising, while a similar number of participants believe the US' influence is declining.
  • In countries like Kenya, South Africa, Nigeria, Austria, Poland and India, more people believe that the US' influence is rising rather than declining.
  • In the US, 32 percent of participants believe their country's international influence is rising while another 32 percent believe the US' influence is declining, while 56 percent believe China's influence is rising.

CGTN: 'New Approaches': Hospitals gear up to prioritize COVID-19 patients

Retrieved on: 
Wednesday, December 14, 2022
Hospital, Omicron, Shanghai Media Group, National Health Commission, ICU, CGTN, Fudan University, Patient, Huashan Hospital, City, Relaxation, Bed, COVID-19, Panic, Quarantine, National Association Medical Staff Services, Bureau, Health insurance, Animal, Pharmaceutical industry, Medicine, Vaccine

The measures require enhancing medical resources to prioritize COVID-19 patients.

Key Points: 
  • The measures require enhancing medical resources to prioritize COVID-19 patients.
  • To avoid panic and a squeeze on medical resources, local governments and hospitals are upgrading existing temporary hospitals, adding ICU beds and better distributing medical resources.
  • China built temporary hospitals to receive and treat COVID-19 patients with mild symptoms and cut off the spread of the virus.
  • "We have set up different areas and provided different channels for different groups of patients to ensure all the patients can receive medical care timely.

CGTN: 'New Approaches': Hospitals gear up to prioritize COVID-19 patients

Retrieved on: 
Wednesday, December 14, 2022
Hospital, Omicron, Shanghai Media Group, National Health Commission, ICU, CGTN, Fudan University, Patient, Huashan Hospital, City, Relaxation, Bed, COVID-19, Panic, Quarantine, National Association Medical Staff Services, Bureau, Health insurance, Animal, Pharmaceutical industry, Medicine, Vaccine

The measures require enhancing medical resources to prioritize COVID-19 patients.

Key Points: 
  • The measures require enhancing medical resources to prioritize COVID-19 patients.
  • To avoid panic and a squeeze on medical resources, local governments and hospitals are upgrading existing temporary hospitals, adding ICU beds and better distributing medical resources.
  • China built temporary hospitals to receive and treat COVID-19 patients with mild symptoms and cut off the spread of the virus.
  • "We have set up different areas and provided different channels for different groups of patients to ensure all the patients can receive medical care timely.

Non-invasive Prenatal Testing Global Market Report 2022: Favourable Reimbursement Scenario Boosts Sector Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 24, 2022
Managed Care, Health, Other Health, Medical Devices, Blood, Marketing, University College London, Chromosome, Down syndrome, Health education, NIPT, Fetus, Opportunity, DNA, Trisomy, Attention, US, Insurance, Genetic counseling, Region, Application, NIPS, Growth, Pregnancy, COVID-19, Infection, Risk, Fudan University, Medical imaging, Health insurance

The "Non-invasive Prenatal Testing Market, by Test Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis,2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Non-invasive Prenatal Testing Market, by Test Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis,2022-2030" report has been added to ResearchAndMarkets.com's offering.
  • Noninvasive prenatal testing (NIPT) is also known as noninvasive prenatal screening (NIPS).
  • Obtaining reimbursement for tests from payers is expected to offer lucrative growth opportunities for players in the global non-invasive prenatal testing market.
  • Moreover, attention towards health education, subsidies for NIPT, and genetic counseling is also expected to aid in growth of the market.

Fifth Blancpain-Imaginist Literary Prize winners announced

Retrieved on: 
Monday, November 21, 2022
International Movement for an Imaginist Bauhaus, Comparative literature, Perseverance, Collection, Fudan University, Reading, Booker Prize, Harvard University, Paganini Competition, Young Friends General Meeting, Multimedia, Book, Love, Speech, Attention, Nobel Prize, Publishing, Entertainment, Literature, Blancpain

BEIJING, Nov. 21, 2022 /PRNewswire/ -- The award ceremony for the fifth Blancpain-Imaginist Literary Prize was held as scheduled on November 9, 2022. Young author Lin Zhao won first prize for her work Chao Xi Tu. The prize, co-sponsored by Swiss luxury watch brand Blancpain and China's most influential cultural brand Imaginist, aims to create a literary award that is impartial, authoritative, professional and enduring while honoring a work that is likely to stimulate international dialogue.

Key Points: 
  • BEIJING, Nov. 21, 2022 /PRNewswire/ --The award ceremony for the fifth Blancpain-Imaginist Literary Prize was held as scheduled on November 9, 2022.
  • The literary prize committee awarded the first prize author a cash prize of300,000 yuan(approx.US$42,400, provided by Blancpain) and a Blancpain Villeret collection watch.
  • Mr Liao,the Blancpain China vice president, said in his speech that "2022 is an extraordinary year, with the Blancpain-Imaginist Literary Prize celebrating its fifth anniversary, a key milestone for the annual event.
  • The Blancpain-Imaginist Literary Prize, co-founded by Swiss luxury watch brand Blancpain and China's most influential cultural brand Imaginist, was created to uncover new and promising literary stars, support talented young authors and encourage the creation of Chinese-languagenovels.

Concord Medical Announces the Successful Holding of the Second Annual Academic Meeting with the world well-known MD Anderson

Retrieved on: 
Wednesday, November 16, 2022
Monroe Dunaway Anderson, Anderson, Fudan University, Forward-looking statement, Meeting, University, Company, Nursing management, Education, NYSE, CCM, Research, Phrase, The Meeting, Patient, Radiation, Renji Hospital, Hospital, Shanghai Cancer Center, Oncology, MD Anderson Cancer Center, Method, Ruijin Hospital, Cancer, Pharmaceutical industry, Medical device, Medical imaging, Immunotherapy, Bedside

12 experts from MD Anderson participated in the Meeting, including nine of which as guest speakers and three as moderators and opening speakers.

Key Points: 
  • 12 experts from MD Anderson participated in the Meeting, including nine of which as guest speakers and three as moderators and opening speakers.
  • Dr. Jianyu Yang, Chairman and Chief Executive Officer of Concord Medical, commented, "I would like to express my heartfelt thanks to the experts who spoke on and participated in the Meeting.
  • MD Anderson is one of the best-known cancer treatment centers globally and the largest cancer center in the United States.
  • Leveraging years of strategic cooperation, MD Anderson and Shanghai Concord Cancer Center successfully cohosted the First Annual Academic Meeting in November 2021.

908 Devices Records Strong Momentum in Life Sciences Sector

Retrieved on: 
Thursday, November 10, 2022
Stem Cells, Biotechnology, Technology, Health, General Health, Pharmaceutical, Health Technology, Medical Devices, Software, Artificial Intelligence, Hardware, CPI, Private Securities Litigation Reform Act, Peptide, MIT, U.S. Securities and Exchange Commission, Intelligence, University of Washington, Boehringer Ingelheim, Nasdaq, ASMS, Symphogen, Research, Society, Fudan University, Technology, TrafFix Devices, Inc. v. Marketing Displays, Inc., Proteomics, Clemson, Oligonucleotide, SEC, Johns Hopkins University, Machine learning, AAV, Bio-Techne, Company, Genentech, Drug development, Cell, Mass spectrometry, University, American Society for Mass Spectrometry, CEO, Security (finance), MASS, Industry, Dana–Farber Cancer Institute, Pharmaceutical industry, Fine chemical

By providing our users with real-time control of critical product and process attributes, 908 Devices is empowering dramatic efficiencies throughout the drug development lifecycle.

Key Points: 
  • By providing our users with real-time control of critical product and process attributes, 908 Devices is empowering dramatic efficiencies throughout the drug development lifecycle.
  • 908 Devices gathered 175 users, in person and virtual, to share insights and successes using its devices.
  • For more information about 908 Devices life sciences capabilities, please visit www.908devices.com .
  • 908 Devices Inc. (Nasdaq: MASS) is democratizing laboratory mass spectrometry with its simple handheld and desktop devices, addressing critical-to-life applications.